Zongertinib positive results non-small cell lung cancer Zongertinib positive results non-small cell lung cancer Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients
Annual Results Press Conference Annual Results Press Conference Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Podcast: Journeys through pulmonary fibrosis Podcast: Journeys through pulmonary fibrosis As we speak to the courageous pulmonary fibrosis community, we hear heart-warming stories of determination, resilience and spirit.
Pet parasites are still here. What's the risk? Pet parasites are still here. What's the risk? What's the risk of pet parasites? They’re a growing challenge due to climate change. Check how to protect your dog and cat from fleas, ticks and more.
Breakthrough introduction innovation pet parasiticides Breakthrough introduction innovation pet parasiticides In 2014, Boehringer introduced a new product, which became the first in a new class of isoxazoline products for flea and tick protection in dogs.
Generalised-Pustular-Psoriasis-Infographic Generalised-Pustular-Psoriasis-Infographic What is GPP? GPP is a rare and chronic autoinflammatory skin disease with recurrent episodes of exacerbations or flares
Exploring beyond boundaries for innovation in animal health Exploring beyond boundaries for innovation in animal health Exploring beyond boundaries by partnering with human pharma and animal health may hold the key to accelerating innovation in animal health.
More Than Scleroderma More Than Scleroderma A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Hidradenitis suppurativa Hidradenitis suppurativa Find out more about hidradenitis suppurativa (HS), a long-term, inflammatory, recurrent, skin disease
Generalized pustular psoriasis is not ‘sensitive’ content Generalized pustular psoriasis is not ‘sensitive’ content Learn about the impact that a lack of online visibility can have on people living with this chronic, inflammatory skin disease.
ACR19 Autoimmune Trial ACR19 Autoimmune Trial ACR Congress 2019 abstract analysing a subgroup of patients with autoimmune diseases in the INBUILD® trial of nintedanib in patients with PF-ILF
Uniting to stop rabies: a global and local endeavor Uniting to stop rabies: a global and local endeavor By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease
Living with type 2 diabetes Living with type 2 diabetes People living with type 2 diabetes often suffer a degree of stigma. Learn from Jurjen de Lange what it takes to live a good life despite the disease.
More Health Overview More Health Overview Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Making more health through animal health Making more health through animal health Boehringer Ingelheim and Ashoka aim to build a world with a greater access to health for people, animals and their communities.
Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD Breakthrough-Therapy-Designation-Progressive-Fibrosing-ILD FDA Grants nintedanib Breakthrough Therapy Designation for Chronic Fibrosing ILDs with a Progressive Phenotype
Life stages of cats Life stages of cats Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.
Access to Healthcare Strategy Innovation Access to Healthcare Strategy Innovation Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
The Unwearable Collection™: Fashion Inspired by GPP The Unwearable Collection™: Fashion Inspired by GPP An introduction to The Unwearable Collection™: fashion inspired by the experiences of living with GPP, designed by Bart Hess
collaboration criving innovation collaboration criving innovation In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
GPP Forum Article - Frida Dunger Johnsson, Executive Director, IFPA GPP Forum Article - Frida Dunger Johnsson, Executive Director, IFPA Frida Dunger Johnsson, Executive Director of IFPA and panelist at the generalized pustular psoriasis (GPP) Forum, reflects on a momentous day